Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples.

Mol Ther

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX, USA. Electronic address:

Published: January 2018

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763145PMC
http://dx.doi.org/10.1016/j.ymthe.2017.12.003DOI Listing

Publication Analysis

Top Keywords

absence replication-competent
4
replication-competent retrovirus
4
retrovirus vectors
4
vectors cell
4
cell products
4
products patient
4
patient follow-up
4
follow-up samples
4
absence
1
retrovirus
1

Similar Publications

Infection of an adult rhesus macaque with SARS-CoV-2 led to viral RNAemia in nose, throat, and lungs. The animal also presented extended fecal shedding of viral genomic and subgenomic messenger RNA and replication-competent virus for more than 3 weeks after infection. Positron emission tomography revealed increased intestinal glucose metabolism which was histologically related to inflammation of the ileum.

View Article and Find Full Text PDF

Rift Valley fever (RVF) is an arboviral zoonotic disease affecting many African countries with the potential to spread to other geographical areas. In this chapter we describe the use of a replication-competent recombinant (r)RVFV expressing NanoLuc Luciferase (Nluc) for in vitro studies. The determination of parameters such as neutralizing antibodies in serum samples, or the antiviral activity of drugs is usually carried out using standard assays based on the assessment of cytopathic effect on cell cultures.

View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection is a serious global health problem causing acute and chronic hepatitis and related diseases. Approximately, 296 million patients have been chronically infected with the virus, leading to cirrhosis and hepatocellular carcinoma. Although HBV polymerase (HBVpol, pol) plays a pivotal role in HBV replication and must be a definite therapeutic target.

View Article and Find Full Text PDF

Unlabelled: Batborne henipaviruses, such as Nipah and Hendra viruses, represent a major threat to global health due to their propensity for spillover, severe pathogenicity, and high mortality rate in human hosts. Coupled with the absence of approved vaccines or therapeutics, work with the prototypical species and uncharacterized, emergent species is restricted to high biocontainment facilities. There is a scarcity of such specialized spaces for research, and often, the scope and capacity of research, which can be conducted at BSL-4, is limited.

View Article and Find Full Text PDF

Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond.

Viruses

September 2024

Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Article Synopsis
  • * A review of literature identified 12 potential vaccines, including promising candidates like SL-V20, HF10, VC2, and mRNA-1608 that are showing strong preclinical results.
  • * Although vaccines such as GEN-003 and HerpV showed initial promise in clinical trials, they haven’t progressed further, but ongoing research is aiming to achieve a breakthrough in HSV prevention and treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!